Cargando…
Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma
Infiltrating low grade gliomas (LGGs) are heterogeneous in their behavior and the strategies used for clinical management are highly variable. A key factor in clinical decision-making is that patients with mutations in the isocitrate dehydrogenase 1 and 2 (IDH1/2) oncogenes are more likely to have a...
Autores principales: | Jalbert, Llewellyn E., Elkhaled, Adam, Phillips, Joanna J., Neill, Evan, Williams, Aurelia, Crane, Jason C., Olson, Marram P., Molinaro, Annette M., Berger, Mitchel S., Kurhanewicz, John, Ronen, Sabrina M., Chang, Susan M., Nelson, Sarah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361089/ https://www.ncbi.nlm.nih.gov/pubmed/28327577 http://dx.doi.org/10.1038/srep44792 |
Ejemplares similares
-
Magnetic resonance analysis of malignant transformation in recurrent glioma
por: Jalbert, Llewellyn E., et al.
Publicado: (2016) -
Characterization of metabolites in infiltrating gliomas using ex vivo
(1)H high-resolution magic angle spinning spectroscopy
por: Elkhaled, Adam, et al.
Publicado: (2014) -
Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas
por: Autry, Adam W., et al.
Publicado: (2022) -
Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade Gliomas()
por: Luks, Tracy L., et al.
Publicado: (2018) -
Metabolic Reprogramming in Mutant IDH1 Glioma Cells
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2015)